{"abstract": "Shire is paying a 51 percent premium for NPS, and it is making a potentially risky deal ahead of an important regulatory ruling, Neil Unmack of Reuters Breakingviews writes.", "web_url": "https://dealbook.nytimes.com/2015/01/12/shire-gambles-abbvie-break-up-fee-on-a-risky-deal/", "snippet": "Shire is paying a 51 percent premium for NPS, and it is making a potentially risky deal ahead of an important regulatory ruling, Neil Unmack of Reuters Breakingviews writes.", "lead_paragraph": "Shire is gambling its AbbVie breakup fee on risky M.&A.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/01/11/business/dealbook/dbpix-shire-nps/dbpix-shire-nps-articleLarge.jpg", "height": 400, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2015/01/11/business/dealbook/dbpix-shire-nps/dbpix-shire-nps-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 400}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/01/11/business/dealbook/dbpix-shire-nps/dbpix-shire-nps-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/01/11/business/dealbook/dbpix-shire-nps/dbpix-shire-nps-superJumbo.jpg", "height": 1365, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2015/01/11/business/dealbook/dbpix-shire-nps/dbpix-shire-nps-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2015/01/11/business/dealbook/dbpix-shire-nps/dbpix-shire-nps-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/01/11/business/dealbook/dbpix-shire-nps/dbpix-shire-nps-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Shire Gambles AbbVie Breakup Fee on a Risky Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "persons", "value": "Ornskov, Flemming", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Shire PLC", "rank": 5, "major": "N"}], "pub_date": "2015-01-12T17:00:20+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Neil Unmack", "person": [{"firstname": "Neil", "middlename": null, "lastname": "Unmack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/072c1e07-d35c-54bb-ba8a-3b654dd86b54", "word_count": 468, "uri": "nyt://article/072c1e07-d35c-54bb-ba8a-3b654dd86b54"}